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Background: Transfusion Transmissible Infections (TTIs) such as Human Immunodeficiency Virus (HIV), syphilis,
hepatitis B virus (HBV) and hepatitis C virus (HCV) are infections which are common in some communities in
Southern Africa. It is important to screen blood donations for these infections.
Methods: This is a retrospective study which involved reviewing of previous blood donation records for the year
2012 in Namibia. The records were analyzed to determine the prevalence of HIV, syphilis, Hepatitis B and C among
blood donations with regard to gender, age and geographical region of the donors.
Results: The findings indicated a significantly low prevalence of HIV, syphilis, HBsAg and anti-Hepatitis C among the
blood donations. A low infection rate of 1.3% by any of the four tested TTIs was found among the blood donations
given by the donor population in Namibia in 2012.
Conclusion: The blood donations given by the donor population in Namibia has a low infection rate with the HIV,
syphilis, HBsAg and anti-HCV. A strict screening regime must continue to be used as the infections are still present
albeit in small numbers.Background
Blood transfusion is a source of transfusion transmissible
infections (TTIs) especially caused by bacteria or viruses.
These are transmitted through transfusion of different
blood products from blood donors to recipients.
Transfusion-associated infections, mainly hepatitis B virus
(HBV), hepatitis C virus (HCV), human immunodefi-
ciency virus (HIV) and syphilis among blood donors are
of public health concern. Blood transfusion practices
worldwide emphasize on safety and protection of human
life. Infections such as HIV, HBV, HCV are of great
concern because of their prolonged viraemia and carrier
or latent state [1]. These are routinely tested on all
donated blood in many parts of the Africa where each unit
of blood collected undergoes strict screening tests to
ensure safety to recipients [2].
Blood transfusion services offered by the Namibia
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article, unless otherwise stated.necessary part of the Namibia health care sector. It is an
integral part of patient treatment through administration
of different blood products to those in need. Proper test-
ing and screening of these TTIs among blood and platelet
donors permits an assessment of the blood donor popula-
tion to ensure safety of the collected donations. It is
necessary to estimate the prevalence of these infections in
the Namibian donor community using more sensitive and
specific tests than the early tests used [3-5].
The battery of screening tests conducted on donor
blood has substantially reduced the risk of TTIs,
although it has increased the cost of providing safe
blood [6]. Screening of potential blood donors has his-
torically relied on the use of immunoassays to detect viral
antibodies or antigens. Currently, besides serological tests,
prevention of transfusion associated infection depends on
use of molecular tests [7,8]. Proper pre-donation selection
of donors, followed by serologic testing for infectious
pathogens, including HBV, HCV and HIV is also necessary
[6]. Since 1999, new screening methods involving nucleic
acid amplification testing (NAT) to detect HIV type 1 andCentral Ltd. This is an Open Access article distributed under the terms of the
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and Drug Administration [9].
Studies have been done in Namibia to determine preva-
lence of TTIs such as hepatitis B and hepatitis C viruses
among blood donors [3-5]. Insensitive countercurrent
electrophoresis, was used among members of the Kwangali
tribe in the west [3]. In another early study the HBsAg
carrier rate was found to be slightly higher but less sensi-
tive methods were used [10]. The varying frequency of the
HBsAg prevalence can be attributed to many factors,
including the socio-economic conditions in which the
people live, the age, sex distribution, genetic make-up of
the population and the risk of exposure to blood-sucking
vectors [4]. There is need to investigate socio-demographic
characteristics that are associated with TTIs. This should
include categorization of donors into regular, first time and
occasional donors. Hepatitis C virus is an important TTI
whose infection leads to long term sequelae including
cirrhosis, liver failure and hepatocellular carcinoma [5].
Hepatitis C virus data from southern Africa are incomplete
since no survey has been published for countries like
Angola and Namibia. Countries in central and southern
Africa show a range of HCV prevalence from <1% to >10%
[5]. Recent review of prevalence of HCV globally based on
the number of people with anti-HCV, has shown that these
increased from 2.3% to 2.8% and from more than 122 mil-
lion to more than 185 million between 1990 and 2005 and
are therefore at risk of developing liver cirrhosis and liver
cancer [11].
The prevalence of HIV infection in Africa varies from
one region to another. In South Africa and Central African
Republic it was respectively 0.10 to 15% in new donors in
2004 [12]. The prevalence rates of HIV-1 decreased after
implementation of safety policies to screen HIV from
donated blood [13]. Despite the screening of blood prod-
ucts, blood transfusion still accounts for 5 to 10% of HIV
infection in Sub-Saharan Africa, similarly 5% to 12% of
patients who received blood transfusion developed hepa-
titis [1]. Like HIV, syphilis is still one of the infections
transmitted through blood transfusion as shown by a high
antibody detection in healthy African blood [14]. In sub-
Saharan Africa, syphilis remains a serious public health
problem. Prevalence of active syphilis infection among
African countries showed 12.8% in Tanzania, and 3.8% in
Kenya [15,16]. The high prevalence of HIV, HBV, HCV and
syphilis has heightened the problems of blood safety in
some parts of Africa [1]. Screening of blood products has
led to a decline in the incidence of acute hepatitis C since
the late 1980s, although rates have reached a plateau in
recent years [17].
Screening of blood bank donors for HBsAg does not to-
tally eliminate the risk of HBV infection since the absence
of this marker in the serum does not exclude the presence
of HBV DNA. Therefore, Nucleic Acid Testing (NAT)blood screening is the key that is originally intended to
complement serological screening for detection of viruses.
The main advantage of NAT screening is detection cases
during the window period [18]. More sensitive tests for
viral antibodies, antigens and nucleic acids have led to
dramatic TTIs and should be used [7].
The study focused on determining the prevalence of TTIs
namely hepatitis B and C, HIV and syphilis among blood
donations in Namibia from 2 January to 31 December for
the year 2012 using a combination of traditional serological
techniques and newer molecular methods. It also investi-
gated the existence of any association between the TTIs




This study is a retrospective study, analyzing blood
donations from donor records for the year 2012. From
the pool of blood donations received by Namibia Blood
Transfusion Services (NAMBTS), these came from new,
lapsed and regular donors. Lapsed donors were those
who had donated previously but had gone for 6 months
without any donation. The study was conducted at the
NAMBTS headquarters in Windhoek, which is the main
provider of blood transfusion services in Namibia and
included some repeat donations.
Study population
The study included 24 761 blood donations from nine
regions of Namibia. These blood donations were all from
voluntary donors mainly selected based on a set criterion
of their age and weight. The individuals were those who
weighed not less than 50 kg and were within the age of 16
to 65 years. A blood donor medical history form was filled
in by the donor before donating blood. It was used for fur-
ther donor selection according to the NAMBTS protocol
for selecting blood donors.
Blood collection
Venous blood was collected from the blood donor in blood
collection tubes upon donating blood. The blood was used
to screen for HIV, syphilis, HBsAg and anti-HCV.
Serology
The blood was screened on the Abbott Prism for Anti-HIV
1/2, HBsAg and anti-HCV and TPHA for syphilis on the
Olympus PK2700. Every reactive result was tested twice
and if both replicates are nonreactive, then the initial react-
ive was interpreted as false positive. Syphilis was tested
using automated Treponema pallidum Haemaglutination
Assay (TPHA) which when reactive twice was then re-
peated using the manual TPHA and VDRL test procedure
Table 1 Prevalence of TTIs among the general blood
donor population of Namibia
Number of donations and percentage
Parameter Total
sample
HIV Syphilis HBsAg HCV
No. (%) No. (%) No. (%) No. (%)











Total 24761 24761 24761 24761 24761
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and gave the final screen outcome.
Nucleic acid testing
The three TTIs HBV, HCV and HIV were tested by means
of Nucleic Acid Testing (NAT) using the Chiron Procleix
Ultrio Plus Assay, Norvatis, USA. This is a molecular
discriminatory assay for HBV, HCV and HIV. All NAT
reactive results were replicated and then discriminated to
identify the virus. If an initial reactive was not repeat
reactive by one or both replicates, this was considered a
false positive result and any repeat reactive NAT that
could not be discriminated was considered to be discordant
and repeat samples collected from the donor after 56 days
for retesting.
The algorithm used was such that negative results from
serology or NAT were interpreted concurrently and both
had to be negative to consider the blood donation as nega-
tive for the tested infectious agents and similarly if both
were positive the final result was considered positive.
Where there was discordant virology with serology being
reactive, the following confirmatory tests were performed;
Immunocomb for anti-HIV only if the NAT was negative;
ElecsysHBsAg neutralization only if the NAT was negative;
and Murex anti-HCV only if the NAT was negative. A
NAT repeat reactive with a nonreactive serology was con-
sidered a window period case, however no further testing
was done to identify occult HBV (OBI).
Statistical analysis
All data were entered into Microsoft Excel spreadsheets
and analyzed using SPSS (version 21, IBM Corp.,
Armonk, NY, USA). The results of each test were re-
trieved and used to determine the prevalence of each of the
four TTIs included in this study. It was then analyzed based
on gender, age and geographical regions from where blood
donors from which the donations came from. Pearson’s χ2
tests or Fisher’s exact tests (when values were lower than 5)
were used for categorical data. Bivariate analyses assessed
associations between population characteristics and TTIs in
the data. Odds ratios (OR) and 95% confidence intervals
(CI) were calculated for all associations. P values less than
0.05 were considered statistically significant.
Ethical considerations
The permission to conduct this study was granted by the
Director of NAMBTS. In addition the ethics committee
within NAMBTS gave ethical approval for the study to
be conducted. With regard to confidentiality no names
were involved in the data analysis process as only codes
were used to identify donors. There was no need for
blood donor consent for this study since the study did
not directly involve donors but rather the donation units
which were not linked to the donor identity.Results
A total of 24761 blood donations were retrieved and ana-
lyzed into different categories. The donations were tested
for four different TTIs.
Table 1 shows the prevalence of the four tested TTIs
based on a positive or negative outcome among the
donor population considered in the study. The table
shows the results of the 24761 blood donations, 316
(1.3%) donations tested positive for HIV, syphilis, HBsAg
and anti-HCV. The remainder (24445 donations) tested
negative for any of the four tested TTIs. It also showed
that HBsAg positive cases were the most common TTIs
among the positive donations and HCV was the least
positive among these donations. There were 3 (1.8%)
cases of HBV and HCV co-infection and 2 (0.9%) cases
of HBV and HIV co-infection and only 1 (1.0%) case of
HIV and HCV co-infection. These co-infections were
overally 0.024% of all the donations.
The gender distribution of donors who contributed
the donations is summarized in Table 2. Donations with
a positive result for the tested TTIs are categorized
based on the gender of the donors to show the preva-
lence of the TTIs among males and females.
A slightly higher number of the donations were from
males than from females. There was no significant differ-
ence between donations from males and females positive
for HIV. Both genders also had a similar HCV positivity.
However HBsAg positivity was slightly higher in males
than in females by 0.3%. There was a significant differ-
ence in infection with syphilis with 0.4% and 0.2%
between females and males infected respectively (OR,
2.11; 95% CI, 1.31-93.39; p = 0.002).
Table 3 shows prevalence of TTIs among blood
donations according to age groups. Age groups of donors
were categorized into age intervals of ten years ranging
from donors ≤20 years of age to donors ≥51 years of age.
Most donations came from the 21-30 years age group.
Age groups of 21-30, 31-40 and 41-50 all had the same
percentage of HIV positive donors. Donations from
those aged more than 51 years old were the least
positive for HIV. For syphilis both age groups of ≤20
and 21-30 years had the least proportion of those testing
positive. An analysis of donations from those aged
Table 2 Prevalence of TTIs among blood donors
according to gender
Number of donations and percentage
Parameter Total
sample
HIV Syphilis HBsAg HCV
No. (%) No. (%) No. (%) No. (%)
Females 11707 37 (0.3) 49 (0.4) 51 (0.4) 11 (0.1)
Males 13054 38 (0.3) 26 (0.2) 89 (0.7) 15 (0.1)
Total 24761 75 (0.3) 75 (0.3) 140 (0.6) 26 (0.1)
Table 4 Prevalence of TTIs among blood donors
according regional location




HIV Syphilis HBsAg HCV
No. (%) No. (%) No. (%) No. (%)
Erongo 4454 17 (0.4) 9 (0.2) 25 (0.6) 2 (0.04)
Hardap 789 0 (0.0) 1 (0.1) 3 (0.4) 1 (0.13)
Karas 668 1 (0.1) 2 (0.3) 10 (1.5) 1 (0.15)
Khomas 15276 45 (0.3) 45 (0.3) 66 (0.4) 19 (0.12)
Kunene 202 0 (0.0) 1 (0.5) 2 (1.0) 0 (0.00)
Omaheke 447 0 (0.0) 3 (0.7) 7 (1.6) 0 (0.00)
Oshana 250 1 (0.1) 5 (2.0) 6 (2.4) 0 (0.00)
Oshikoto 746 6 (0.8) 0 (0.0) 10 (1.3) 1 (0.13)
Otjozondjupa 1929 5 (0.3) 9 (0.5) 11 (0.6) 2 (0.10)
Total 24761 75 (0.3) 75 (0.3) 140 (0.6) 26 (0.1)
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cantly infected with syphilis compared to all other age
groups (OR, 5.70; 95% CI, 1.34-24.15; p = 0.018). Both
age groups of donors who were ≤20 and 21-30 years,
had the same percentage of 0.8% positive for HBsAg, the
highest among all the four TTIs. Donations from those
above 51 years were the least positive for HBsAg. The
percentage of those who tested positive for anti-HCV
was the same for all age groups except those less than
21 years which was twice as much as the other age
groups.
Blood donations from different regions of Namibia are
presented in Table 4 to show the prevalence of TTIs
among blood donations in those geographical regions.
The findings indicated that Oshikoto region had the
highest percentage of positive donations for HIV while
Hardap, Kunene and Omaheke regions showed no posi-
tive HIV donations. Oshana region had the highest do-
nations testing positive for both syphilis and HBsAg.
Donations from this region were significantly positive
for syphilis than any other region (OR, 4.37; 95% CI,
1.45-13.13; p = 0.009). Infection with HCV was the least
positive among blood donations in all regions as it was
below 0.2%.
Table 5 summarizes the different types of donors who
contributed to the donations whilst Table 6 shows the
donations that were positive for different TTIs based on
donor types. It is apparent that most positive donations
were coming from new donors irrespective of the type
of TTI.Table 3 Prevalence of TTIs among blood donors
according age groups





HIV Syphilis HBsAg HCV
No. (%) No. (%) No. (%) No. (%)
≤20 4501 18 (0.4) 6 (0.1) 38 (0.8) 9 (0.2)
21-30 7217 22 (0.3) 9 (0.1) 55 (0.8) 6 (0.1)
31-40 5958 17 (0.3) 26 (0.4) 22 (0.4) 4 (0.1)
41-50 4171 12 (0.3) 26 (0.6) 19 (0.5) 3 (0.1)
≤51 6 (0.2) 8 (0.3) 6 (0.2) 4 (0.1)
Total 24761 75 (0.3) 75 (0.3) 140 (0.6) 26 (0.1)Discussion
This study showed that 1.3% of the donations included
in the study were for at least one of the four TTIs. This
was relatively a low prevalence when compared to other
studies conducted in other African countries such as
Tanzania with 15.9% [19] and Ethiopia with 9.5% [3] of
blood donors positive for at least one of the mentioned
TTIs. According to a report by the Ministry of Health
and Social Services (MoHSS) in 2005, HIV and Hepatitis
B infection caused blood to be discarded in 7% of blood
donations. The prevalence of other screened infections
by syphilis and Hepatitis C were 2% [20] indicating that
HIV and Hepatitis B had been the most prevalent TTIs
among blood donors.
In comparison to the general prevalence of TTIs among
donor populations of other African countries, it can be
clearly stated that blood donors in Namibia are relatively
healthier than other African blood donor populations with
regard to the TTIs mentioned. The prevalence found in
the donor population may not be the most appropriately
suitable for comparison with the general population due
to blood donor selection procedures involved in selecting
donors. Blood donors undergo pre-donation screening for
risk factors, which is aimed to exclude donors potentially









New 3928 3928 1
Lapsed 2840 2840 1
Repeat 5988 17993 3
Total 12756 24761 1.9












No. (%) No. (%) No. (%) No. (%) No. (%)
New 13 (48.1) 35 (46.7) 117 (84.2) 39 (52.0) 204 (64.6)
Lapsed 5 (18.5) 16 (21.3) 8 (5.8) 16 (21.3) 45 (14.2)
Repeat 9 (33.3) 24 (32.0) 14 (10.1) 20 (26.7) 67 (21.2)
Total 27 75 139 75 316
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TTIs analyzed in this study.
Prevalence of HIV and syphilis among the donor popu-
lation was 0.3% for both TTIs. These findings are similar
with those presented by the Centre for Disease Control
and Prevention (CDC) weekly reported dated 25 Novem-
ber 2011. The reported indicated that the HIV prevalence
among Namibian blood donors between the year 2003 to
2008 ranged from 0.3% to 0.7% [21]. This means there has
been little variation of HIV prevalence among blood
donors during the period of years indicated.
The 0.3% of syphilis positive donations among Namibian
donors was very low compared to other findings of studies
done in other African countries. In Ghana, 7.5% of blood
donors were positive for syphilis in year 2003 [14]. In
Ethiopia, 1.8% of blood donors was found to be positive for
syphilis [1], and another study conducted in Tanzania
found 4.7% syphilis positive donors [19]. The lower preva-
lence of syphilis in Namibia in comparison to other coun-
tries may be caused by factors related to different blood
donor sampling procedures used in those studies.
Hepatitis B was the most prevalent TTI with 0.6% of the
blood donations positive for HBsAg. This may be signifi-
cantly low among the donor population but it may also
indicate significance among the general population. Accor
ding to World Health Organization, in year 2006 about
243700 Namibians were found positive with Hepatitis B
infections which accounted for 10% of the entire popula-
tion of Namibia [22]. Infection with HCV was found to be
the least with 0.1% donors positive and this was different
from the infections rates found in 1999 which indicated
0.9% HCV positive blood donors [5]. This implies that
there have been decreases in HCV infections among blood
donors which may be possibly caused improved donor se-
lection protocols or alternatively a decrease of HCV among
the general population.
The similarity of HIV prevalence among male and female
(both 0.3%) blood donations may be due to the reason that
both genders are at risk of this infection in a similar man-
ner which mainly unsafe sexual activities. This similarity
can also be reflected in other studies from other region
which also showed no significant difference of HIV preva-
lence among male and females. In Tanzania, male blood
donors were accounted for 3.8% while female blood donorsaccounted for 4.0% [19]. The prevalence of syphilis among
male and female donors does however show a difference in
infection rate. Females were found with higher positive
percentage compared to males. Syphilis is generally known
to be more prevalent in females rather than in males in
Namibia although there are no studies support and explain
this observation. In other studies, the ratio of male to
female positive for syphilis was reported as 1.4%:0.9% in
Ethiopia and 4.8%:4.0% in Tanzania [1,19].
Prevalence of hepatitis B showed a significant differ-
ence among male and females with 0.7% males and 0.4%
females positive. However HCV infection rate was not
different between males and females. There may be no
apparent specific factors attributed to these findings but
other studies also reported the similar prevalence differ-
ences among genders. In Tanzania males were more
positive for Hepatitis B than female with a ratio of males
to females as 9.1%:6.3%, HCV was reported with a ratio
of 1.5%:1.1% [19].
The prevalence of HIV in donations in those aged in the
range ≤20 years to donors of 50 years old was between 0.3
to 0.4 which was higher compared to donors above the
age of 51 years. The age group with a higher HIV preva-
lence is consistent with people who are more sexually
active than other age groups thus increasing their risk of
contracting HIV through unsafe sexual practices. Accord-
ing to the national data provided by the MoHSS, HIV
prevalence is increased among people between the ages of
20 to 40 years and decreased among people above the age
of 50 years similar to the findings presented in this study.
Similar findings were also reported in Tanzania where
higher prevalence of HIV was recorded among blood
donor of the same ages indicated [19].
The prevalence of TTIs among different regions in
Namibia varies from among different regions although the
prevalence was low across different regions. Oshikoto
region was found with the highest prevalence for HIV
positive blood donations. According to the National data
of pregnant women in Namibia provided by the MoHSS
in 2005 and 2006, Oshana region had the highest preva-
lence (21%), Oshikoto region (19%) followed by both
Omusati and Khomas (16%) regions and the lowest being
Kunene region standing at 6% [20]. These findings may
however not precisely reflect the prevalence of the blood
donor population due donor selection processes involved.
Oshana region had the highest prevalence of syphilis
and hepatitis B (2.0% and 2.4% respectively) among all
other regions. There may be no other studies conducted to
support these findings of increased prevalence of syphilis
in Oshana region. With regard to increased prevalence of
hepatitis B, this infection is easily transmitted in common
activities especially in poor sanitation areas such as those
found in Oshana region and other regions in northern
Namibia. Hepatitis C virus was the least prevalent among
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lence HCV in the general population. Namibia has 13
regions however only 9 nine regions were used for this
study. This is because the NAMBTS only collects blood
from these nine regions, excluding the other four which
are, Okavango, Caprivi, Omusati and Ohangwena region.
The NAMBTS can use the findings of this study to evaluate
the health and safety of the blood donors in order to insti-
tute improvements that ensure blood safety. It is important
for NAMBTS to consider including blood donors from
other regions especially the rural population as this might
increase the blood donor population, thus increasing blood
for the organization.
It also showed that new donors are often the ones that
contribute to the bulk of the donations that are positive
for TTIs. Regular donors remain an important source of
safe blood for Namibia.
Limitations
The study mainly focused on the donations for only one
year. A more comprehensive analysis of the donor charac-
teristics would have been obtained if the data was ana-
lyzed for several years. The presence of elite controllers
within a donor population is often possible if data is from
a much larger population and is from a longer period. It is
often preferred to analyze data comprising only one dona-
tion per person per year for easy of comparison with other
studies. However categorization of data based on type of
donor in this study gave some indication of the source of
most TTIs.
Conclusion
The findings of this study show a significantly low preva-
lence of the four TTIs in this population. This is an indica-
tion that blood donors in Namibia are relatively healthy
especially the regular donors. The selection criteria for
donors and use of a combination of screening methods
improve selection of donors who provide safe blood. The
findings of this study may not reflect to true prevalence of
these infections in the general population as those who are
aware that they are HIV positive do not come forward to
donate. Even though the prevalence of these TTIs are very
low among the blood donor population, it is still very
necessary for each unit of blood collected to go through a
strict screening process because the infections are still
present albeit in very small numbers.
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